233 related articles for article (PubMed ID: 21963468)
1. Transdermal and transbuccal drug delivery systems: enhancement using iontophoretic and chemical approaches.
Hu L; Silva SM; Damaj BB; Martin R; Michniak-Kohn BB
Int J Pharm; 2011 Dec; 421(1):53-62. PubMed ID: 21963468
[TBL] [Abstract][Full Text] [Related]
2. Enhanced in vitro transbuccal drug delivery of ondansetron HCl.
Hu L; Damaj BB; Martin R; Michniak-Kohn BB
Int J Pharm; 2011 Feb; 404(1-2):66-74. PubMed ID: 21056647
[TBL] [Abstract][Full Text] [Related]
3. Effects of iontophoresis and chemical enhancers on the transport of lidocaine and nicotine across the oral mucosa.
Wei R; Simon L; Hu L; Michniak-Kohn B
Pharm Res; 2012 Apr; 29(4):961-71. PubMed ID: 22134780
[TBL] [Abstract][Full Text] [Related]
4. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
[TBL] [Abstract][Full Text] [Related]
5. Transdermal absorption of memantin--effect of chemical enhancers, iontophoresis, and role of enhancer lipophilicity.
del Rio-Sancho S; Serna-Jiménez CE; Calatayud-Pascual MA; Balaguer-Fernández C; Femenía-Font A; Merino V; López-Castellano A
Eur J Pharm Biopharm; 2012 Sep; 82(1):164-70. PubMed ID: 22732268
[TBL] [Abstract][Full Text] [Related]
6. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
[TBL] [Abstract][Full Text] [Related]
7. Effect of permeation enhancers on the iontophoretic transport of metoprolol tartrate and the drug retention in skin.
Nair A; Vyas H; Shah J; Kumar A
Drug Deliv; 2011 Jan; 18(1):19-25. PubMed ID: 20726811
[TBL] [Abstract][Full Text] [Related]
8. Iontophoretic transdermal delivery of buspirone hydrochloride in hairless mouse skin.
Al-Khalili M; Meidan VM; Michniak BB
AAPS PharmSci; 2003; 5(2):E14. PubMed ID: 12866941
[TBL] [Abstract][Full Text] [Related]
9. Combination strategies for enhancing transdermal absorption of sumatriptan through skin.
Femenía-Font A; Balaguer-Fernández C; Merino V; López-Castellano A
Int J Pharm; 2006 Oct; 323(1-2):125-30. PubMed ID: 16809010
[TBL] [Abstract][Full Text] [Related]
10. In vitro transdermal iontophoretic delivery of penbutolol sulfate.
Ita KB; Banga AK
Drug Deliv; 2009 Jan; 16(1):11-4. PubMed ID: 19555303
[TBL] [Abstract][Full Text] [Related]
11. Transdermal drug delivery enhanced by low voltage electropulsation (LVE).
Sammeta SM; Vaka SR; Murthy SN
Pharm Dev Technol; 2009; 14(2):159-64. PubMed ID: 19519188
[TBL] [Abstract][Full Text] [Related]
12. Enhanced transbuccal salmon calcitonin (sCT) delivery: effect of chemical enhancers and electrical assistance on in vitro sCT buccal permeation.
Oh DH; Chun KH; Jeon SO; Kang JW; Lee S
Eur J Pharm Biopharm; 2011 Oct; 79(2):357-63. PubMed ID: 21683790
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and enhancing effect of dodecyl 2-(N,N-dimethylamino)propionate on the transepidermal delivery of indomethacin, clonidine, and hydrocortisone.
Büyüktimkin S; Büyüktimkin N; Rytting JH
Pharm Res; 1993 Nov; 10(11):1632-7. PubMed ID: 8290477
[TBL] [Abstract][Full Text] [Related]
14. In-vitro characterization of buccal iontophoresis: the case of sumatriptan succinate.
Telò I; Tratta E; Guasconi B; Nicoli S; Pescina S; Govoni P; Santi P; Padula C
Int J Pharm; 2016 Jun; 506(1-2):420-8. PubMed ID: 27113869
[TBL] [Abstract][Full Text] [Related]
15. Transdermal iontophoretic delivery of a liquid lipophilic drug by complexation with an anionic cyclodextrin.
Juluri A; Narasimha Murthy S
J Control Release; 2014 Sep; 189():11-8. PubMed ID: 24950431
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo evaluation of a hydrogel-based prototype transdermal patch system of alfuzosin hydrochloride.
Nair AB; Vaka SR; Gupta S; Repka MA; Murthy SN
Pharm Dev Technol; 2012; 17(2):158-63. PubMed ID: 20958130
[TBL] [Abstract][Full Text] [Related]
17. Delivery of a classical antihypertensive agent through the skin by chemical enhancers and iontophoresis.
Nair A; Reddy C; Jacob S
Skin Res Technol; 2009 May; 15(2):187-94. PubMed ID: 19622129
[TBL] [Abstract][Full Text] [Related]
18. Development of antimigraine transdermal delivery systems of pizotifen malate.
Serna-Jiménez CE; del Rio-Sancho S; Calatayud-Pascual MA; Balaguer-Fernández C; Femenía-Font A; López-Castellano A; Merino V
Int J Pharm; 2015 Aug; 492(1-2):223-32. PubMed ID: 26196273
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo transdermal iontophoretic delivery of naloxone, an opioid antagonist.
Yamamoto R; Takasuga S; Yoshida Y; Mafune S; Kominami K; Sutoh C; Kato Y; Yamauchi M; Ito M; Kanamura K; Kinoshita M
Int J Pharm; 2012 Jan; 422(1-2):132-8. PubMed ID: 22108639
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of nortriptyline penetration through human epidermis: influence of chemical enhancers and iontophoresis.
Merino V; Micó-Albiñana T; Nácher A; Díez-Sales O; Herráez M; Merino-Sanjuán M
J Pharm Pharmacol; 2008 Apr; 60(4):415-20. PubMed ID: 18380912
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
